The latest question of the month is here 🚨
Do you know the answer to this one ⁉️

Visit our website or let us know what you think in the comments ⤵️
loom.ly/bqADPNk

#SPPM #SPPM2026 #pedspain #anesthesiology #anesthesia #pediatric

#PBC Must Read: The Development and Refinement of a Web-Based Sexual Health Education #Intervention for #Pediatric #Oncology #Physicians and Advanced Practice Providers Caring for Adolescents and Young Adults With #Cancer
Read more: onlinelibrary.wiley.com/doi/10.1002/...

All east coast kin. If you have #type2 #diabeties #heartcondition #pediatric #geriatric. Get cool asap. Sweating is a way of body cooling itself. A portable ac coooling fan will be a #lifesaver. I dont care if others think it looks silly. Your health us 10000% important. I am wearing one now.

Crowdsourcing ask: we have a little 2 yo friend who is tube feeding. Parents do *not* have health insurance. I am aware of the Oley Foundation.

Are there other resources we should explore for them?

#enteral #TubeFeeding #pediatric

#PBC Must Read: Clinical Course and Impact of Breaks in #Therapy for Children With Relapsed/Refractory Solid #Tumors #Pediatric #Oncology #Hematology #PedsHemeOnc #PHODocs #MatthewMcEvoy #ElizabethSeashore #WSusanCheng
Read more: onlinelibrary.wiley.com/doi/10.1002/...

Figure 1, "Illustration of Bedside Assessment of Ocular Motor Function," shows methods for testing eye movement: A) Near-point convergence; B) Smooth-pursuit eye movements; C) Saccadic eye movements. Text: JAMA@1, JAMA@2, text@3, text@4

An estimated 1.1 million to 1.9 million #pediatric concussions occur annually in the US.

📊 This JAMA Rational Clinical Examination reviews the diagnostic accuracy of symptoms and signs observed in the initial evaluation of a child or adolescent who may have had a concussion.

ja.ma/41l6Kh4

#PBC Must Read: Validation of D-Dimer as a Prognostic Biomarker in Transplant-Associated #Thrombotic #Microangiopathy in Children #Pediatric
onlinelibrary.wiley.com/doi/10.1002/...

New data for pediatric endocrinology:

Personalized growth hormone therapy shows significant efficacy in improving adult height even during late puberty (Tanner stages IV & V).

Timing and individualization are everything!

#MedSky #Endocrinology #Growth #pediatric

Quote from JAMA by James Donald Fortenberry, MD: "I had been a part of caring for so many patients who had defied death. Why hadn't my own grandson also become a miracle?" Title: A Piece of My Mind.

"I knew other medical colleagues who could never return to the hospital where they had lost a child or loved one, and I understood."

In #APieceofMyMind, a #pediatric #CriticalCare #physician reflects on the death of his infant grandson.

ja.ma/4tAHIqc

Only two weeks away until APASL 2026! Don't miss AASLD's session about global genetic-based diagnostics in #adult and #pediatric liver diseases at the AASLD-APASL Joint Symposium Program.

Register now: https://www.apasl2026istanbul.org/

NEW: The Effect of Electronic Health Record-Based Central Line Maintenance Documentation on #CLABSI Rates across Intensive Care Units at a #Pediatric Hospital www.thieme-connect.com/products/ejo...

#MedSky #PedSky #CriticalCare #EHR #HealthIT #ICU

#VijaySankaran#PedsHemeOnc #PHODocs #Pediatric #Hematology #Oncology

Promising New Therapy for Children with Rare and Aggressive Cancers The article likely discusses a newly developed treatment that has shown potential in helping children suffering from rare and aggressive forms of cancer. Although details are unavailable due to access restrictions, such treatments often involve advanced therapies such as immunotherapy, gene therapy, or targeted drugs designed to attack specific cancer cells without harming healthy tissue. Experts may highlight the potential of this treatment to improve survival rates and quality of life for pediatric patients who previously had limited options. Additionally, clinical trials and ongoing research are crucial to determine the treatment's efficacy, safety, and long-term outcomes. Support from medical communities, hospitals, and families of affected children is essential to facilitate access and ensure equitable distribution of these innovative therapies. The news emphasizes hope and scientific progress in pediatric oncology, aiming to bring attention to the importance of funding, research, and awareness of rare cancers in children.

Promising New Therapy for Children with Rare and Aggressive Cancers

🤖 IA: It's not clickbait ✅
👥 Usuarios: It's not clickbait ✅

#cancer #pediatric #treatment

View full AI summary:

Volume 140 - Issue 3 - The Journal of Laryngology & Otology AB54BA3561CADE7146EDBB0EE9119D1D

📢Mar - Issue 3 of The JLO is now published

Featuring:
🔹 #pediatric #septoplasty
🔹 mapping review of #pediatricresearch
🔹 pediatric #subglottic #stenosis
🔹 cutaneous #SCC standards
🔹 sudden #hearing loss #ssnhl
🔹& more

👇 Read online
www.jlo.co.uk/the-journal/...
#OpenAccess

Music Therapy in the NICU - What is music therapy? How does it help premature babies? And what evidence supports its use? Tune in to find out!

#pediatric #MedEd #podcast #MusicTherapy #NICU @nationwidekids bit.ly/4mhGFcu

We consider Duchenne Muscular Dystrophy. This genetic condition is a serious diagnosis, but there is also progress happening in diagnosis, treatment, and support for those with the condition

#pediatric #podcast #Duchenne #MuscularDystrophy @nationwidekids bit.ly/4slErdt

Key Points In this sample of 120 children with pain-predominant Disorders of Gut-Brain Interaction (DGBI) and their caregivers, 102 of the 120 caregivers (85%) indicated that their child had experienced at least one adverse childhood experience (ACE). ACEs due to maltreatment were significantly correlated with greater 7 day average abdominal pain intensity, poorer health-related quality of life (HRQoL), greater anxiety, and greater depression, while ACEs due to household challenges and social context were not significantly correlated. The experience of maltreatment accounted for significant portions of variance in 7-day average abdominal pain intensity and HRQoL, respectively, even after controlling for anxiety and depression.

🆕🔥#AdverseChildhoodExperiences due to #maltreatment are associated with #AbdominalPain intensity, poorer health-related quality of life, greater anxiety, and greater depressive symptoms, #Pediatric patients with #DGBI‼️
👉 onlinelibrary.wiley.com/doi/10.1111/...
#ANMS #ESNM #PEARLS

Prevalence of pediatric cannabidiol prescribing in the United States

Link:
link.springer.com/article/10.1...

#meded #science #news #pediatric #medical #health #academic

#mHealth-Enabled Stroke Screening for #Pediatric Sickle Cell Disease in Low-Resource Settings: Systematic Literature Review of Critical Barriers, Emerging Technologies, and AI-Driven Solutions Background: Sickle cell disease (SCD) is a genetic blood disorder affecting millions globally, with life-threatening complications, and most patients live in sub-Saharan Africa. Particularly, #Children with SCD have a high risk of stroke. Although early screening for stroke could help prevent many cases, access to effective stroke screening remains limited in low-resource settings (LRS). Existing traditional approaches are highly operator-dependent, costly, resource-intensive, or difficult to deploy at scale in #Pediatric care. These limitations highlight the urgent need for accessible, scalable, and #Child-appropriate stroke screening and assessment tools suitable for low-resource health care contexts. Objective: The aims of this systematic literature review are to (1) uncover system-level barriers affecting stroke screening accessibility for patients with #Pediatric sickle cell disease (PSCD) in LRS, including underserved contexts within high-income countries; (2) identify existing and emerging stroke screening and assessment technologies and their implementation characteristics, such as feasibility, scalability, portability, and training requirements; and (3) propose a user-centered mobile health (#mHealth) framework for stroke screening that improves accessibility and feasibility in resource-constrained health care settings. Methods: PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines were followed to organize the search process. A systematic search was conducted using an advanced query and defined eligibility criteria in the academic databases of PubMed, IEEE Xplore, Wiley Online Library, and Google Scholar. Studies published in English between January 1, 2021, and October 31, 2025, were selected. Collected data were arranged in a preformatted Microsoft Excel spreadsheet for analysis. Risk-of-bias assessment was performed using various risk-of-bias assessment tools because of the heterogeneity of the included studies. Narrative synthesis was used for data synthesis. Results: The literature search initially identified 1465 studies, of which 28 (2%) were selected for analysis. Among the 28 studies, 10 (36%) focused on stroke screening accessibility for patients with PSCD in either low- and middle-income countries or other income-level countries for LRS, and 18 (64%) outlined key features and the feasibility of stroke screening technologies. Identified barriers were organized into 4 major categories (workforce and training constraints, health care system and infrastructure barriers, sociocultural and awareness factors, and economic and logistical constraints), emphasizing difficulties in accessing stroke screening in LRS. Additionally, existing and emerging stroke screening technologies were classified into 5 groups: nonimaging, imaging, light-based optical spectroscopy, biomarker-based, and artificial intelligence– and machine learning–based #mHealth wearable approaches. Finally, a comprehensive #mHealth app is proposed for an easy-to-use screening experience to address stroke screening challenges for patients with PSCD in LRS. Conclusions: This study contributes to identifying major barriers to stroke screening in LRS and highlights key characteristics of stroke screening solutions that can be used in the future. It also contributes to the design of a holistic #mHealth solution for implementing stroke screening clinical care for patients with PSCD in LRS. Trial Registration: PROSPERO 2025 CRD420251172487; https://tinyurl.com/3djampu6

JMIR Pediatrics: #mHealth-Enabled Stroke Screening for #Pediatric Sickle Cell Disease in Low-Resource Settings: Systematic Literature Review of Critical Barriers, Emerging Technologies, and AI-Driven Solutions

#Pediatric #Oncology #Hematology #PedsHemeOnc #PHODocs
#AnnemiekeLittooij #CatiaOlianti #HerveBrisse #PierLuigiDiPaolo #MariaGarganese #TejasKapadia #JurgenSchaefer #HughWallace #Simon Wan #BartdeKeizer #IrminaSeficPasic #JulianRogasch

Findings from a retrospective study on trends in #hydroxyurea (HU) use in #pediatric #SCD following the 2014 #NHLBI guidelines suggest that a lower age of HU initiation may have contributed to a decrease in #cerebrovascular disease: https://ow.ly/LHy050YCneB
#HemeSky #SickleCellDisease

Figure 1, "Illustration of Bedside Assessment of Ocular Motor Function," shows methods for testing eye movement: A) Near-point convergence; B) Smooth-pursuit eye movements; C) Saccadic eye movements. Text: JAMA@1, JAMA@2, text@3, text@4

An estimated 1.1 million to 1.9 million #pediatric concussions occur annually in the US.

📊 This JAMA Rational Clinical Examination reviews the diagnostic accuracy of symptoms and signs observed in the initial evaluation of a child or adolescent who may have had a concussion.

ja.ma/41l6Kh4

#PedsHemeOnc #PHODocs #Pediatric #Hematology #Oncology #PeterNewburger

#PBC Must Read: Group 4 #Medulloblastomas of Early Childhood Treated With High-Dose #Chemotherapy- and #Craniospinal Irradiation-Sparing Approach #Pediatric
#Oncology #Hematology #PedsHemeOnc #PHODocs #PatriciaOrduña #RoseDaynielleCansanay #CraigErker
onlinelibrary.wiley.com/doi/10.1002/...

The #doodles and I value this opportunity to temporarily commandeer a new whiteboard in clinic!
We can share a little #pediatric joy all the while…

Join leading policy and field experts at #ASPHO2026 for a timely #advocacy session, "Shaping Policy, Protecting Patients," and learn how current policy and funding decisions are impacting #pediatric #hematology and #oncology, research, and access for patients.
Register: aspho.org/meetings/con...

Celebrate neurodiversity. Join us in building a more inclusive future.

#autismawareness #ACOP #pediatric #osteopathic

#Pediatric #Hematology #Oncology #Hemoglobinapothies #BloodDisorders

Challenges and overcoming strategies in CAR-T cell therapy for pediatric neuroblastoma.

#pediatric #Meded #Medx #Science #CART #therapy #Neuroblastoma

#ASPHO2026 #PedsHemeOnc #PHODocs #Pediatric #Hematology #Oncology #BloodDisorders #HemeSky #MedSky